Aug 7th, 2018
Presale Closed!

The presale of Lifex token has now closed!

Thank you for your participation, and we will be updating the next token sale date through our website soon.

July 28th, 2018
Presale and KYC registration is now open!

We are thrilled to announce that the presale and KYC registration for joining has now officially opened!

We ask anyone interested in our project to read our whitepaper very carefully, and only join our sale if qualified.

Thank you for your understanding.

July 9th, 2018
New members in LIFEX and presale date determined

We are excited to announce that there will be new members joining our LIFEX project!

-Mr. Yoshitake Awa (CEO of LIFEX RESEARCH PTE. LTD.)
-Mr. Winston Patrick Eric Koike (Advisor of LIFEX Project)

The changes are to be made to expand the business model of LIFEX project with unique backgrounds in the finance industry of above members.

Also due to the changes, the schedule of LIFEX token sale is rescheduled, and the presale is currently scheduled to take place on July 28th, 2018. We will be updating more information of the sales soon.

Below are the profile of Mr. Awa and Mr. Koike:

Awa has a vast experience and knowledge in financial industry through his 30 years of career in Japan, US and Singapore. He has held various positions at major investment banks and asset managers, such as Nomura Securities, Barclays de Zouete Wedd, BNP Paribas and UOB Asset Management.

Winston Patrick Eric Koike is the Director of AP Investment Advisory Services Pte. Ltd. director of AP Advisory Services Ltd., Kenzo Capital and Kenzo GmbH. From many years of working experiences in Morgan Stanley, HSBC and other large finance group, he continuously have been serving for many partners across the world.

Mr. Awa comments as below:
“I believe that the combination of advance medicine and blockchain technology will be the significant characteristic of LIFEX project. I also think the partnership with I’ROM Group of Japan enables us to enhance the quality of our service because of its wide networks with medical institutions & pharmaceutical companies and achievements in advance medical treatment business. I hope my years of working experience and personal connection cultivated in finance industry can be utilized for the future prosperity of our firm.